Postintravitreal Injection Endophthalmitis: Incidence, Characteristics, Management, and Outcome

Table 3

Best corrected visual acuity (logMAR) in post-IVI endophthalmitis along the study period.

	BCVA (logMAR)	BCVA (Snellen)
Baseline, median (IQR)	0.30 (0.18–0.70)	≈6/12
At presentation, median (IQR)	1.78 (0.82–2.10)	≈6/120-CF
Change from the baseline	+1.26 ([+0.40]–[+1.68])
At 6 m follow-up, median (IQR)	0.61 (0.30–1.07)	≈6/24
Change from the baseline	+0.19 ([0.00]–[+0.44])
Change from presentation	−0.88 ([−1.30]–[−0.20])
At 12 m follow-up, median (IQR)	0.74 (0.27–1.32)	≈6/24
Change from the baseline	+0.19 ([0.00]–[+0.62])
Change from presentation	−0.92 ([−1.18]–[−0.05])

IQR: interquartile range; IVI: intravitreal injection; logMAR: logarithm of the minimum angle of resolution.